Jiali Yang

Chongqing, 400044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

A layered double hydroxide nanocarrier enables YM155 delivery-induced PANoptosis and immunogenic activation in hepatocellular carcinoma.

A layered double hydroxide nanocarrier enables YM155 delivery-induced PANoptosis and immunogenic activation in hepatocellular carcinoma.

Journal: RSC advances

Published: February 16, 2026

Deorphanization of the odorant receptor CsepOR1 identifies a biphasic behavioral modulator in Coccinella septempunctata (Coleoptera: Coccinellidae).

Deorphanization of the odorant receptor CsepOR1 identifies a biphasic behavioral modulator in Coccinella septempunctata (Coleoptera: Coccinellidae).

Journal: Pest management science

Published: January 15, 2026

A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer.

A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer.

Journal: Bioactive materials

Published: September 01, 2025

SLC6A14-mediated carnitine transmembrane uptake from PPARγ+ cancer-associated fibroblasts promotes recurrence of pancreatic cancer.

SLC6A14-mediated carnitine transmembrane uptake from PPARγ+ cancer-associated fibroblasts promotes recurrence of pancreatic cancer.

Journal: Gut

Published: June 11, 2025

Integrating mixed reality, augmented reality, and artificial intelligence in complex liver surgeries: Enhancing precision, safety, and outcomes.

Integrating mixed reality, augmented reality, and artificial intelligence in complex liver surgeries: Enhancing precision, safety, and outcomes.

Journal: iLIVER

Published: January 21, 2025

Establishment of M2 macrophage-related prognostic signature in pancreatic ductal adenocarcinoma.

Establishment of M2 macrophage-related prognostic signature in pancreatic ductal adenocarcinoma.

Journal: Discover oncology

Published: October 24, 2024

Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Journal: Pancreas

Published: September 11, 2024

Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence.

Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence.

Journal: BMC cancer

Published: October 31, 2023

The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.

The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: August 14, 2023

Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma.

Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: June 16, 2023

Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Journal: Frontiers in oncology

Published: May 08, 2023

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Journal: Frontiers in oncology

Published: January 05, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026